INS and Insulin resistance: The assessment of β-cell function from baseline to Week 24 showed that both fotagliptin and alogliptin were associated with significant improvements in homoeostasis model assessment of β-cell (HOMA-β) compared with baseline, but no treatment related differences were recorded for HOMA index of insulin resistance (HOMA-IR), or fasting insulin concentration.